Fundies.
English

Segment disclosures

Company overview

Aquestive Therapeutics, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 16 retained observations 11 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=aqst:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3013819000 USD20260811Open filing evidence
2026-01-01 – 2026-06-3028265000 USD20260811Open filing evidence
2026-01-01 – 2026-03-3114446000 USD20260513Open filing evidence
2025-01-01 – 2025-12-3144545000 USD20260304Open filing evidence
2025-07-01 – 2025-09-3012807000 USD20251105Open filing evidence
2025-01-01 – 2025-09-3031530000 USD20251105Open filing evidence
2025-04-01 – 2025-06-3010003000 USD20260811Open filing evidence
2025-01-01 – 2025-06-3018723000 USD20260811Open filing evidence
2025-01-01 – 2025-03-318720000 USD20260513Open filing evidence
2024-01-01 – 2024-12-3157561000 USD20260304Open filing evidence
2024-07-01 – 2024-09-3013542000 USD20251105Open filing evidence
2024-01-01 – 2024-09-3045694000 USD20251105Open filing evidence
2024-04-01 – 2024-06-3020099000 USD20250811Open filing evidence
2024-01-01 – 2024-06-3032152000 USD20250811Open filing evidence
2024-01-01 – 2024-03-3112053000 USD20250512Open filing evidence
2023-01-01 – 2023-12-3150583000 USD20250305Open filing evidence